skip to Main Content

New Zolgensma Clinical Trial

  • 21 April 2021

A new clinical trial is starting for gene therapy for patients who are: Symptomatic SMA diagnosis based on gene mutation analysis with bi-allelic survival motor neuron 1 (SMN1) mutations (deletion or point mutations) and any copy of the survival motor…

Read More
Back To Top